Pharma Journalist -

Elbit Imaging Ltd. announced that it was informed by Gamida Cell Ltd., an indirect associate of the Company, that the orphan drug designation, which has been granted by the European…
Read More...

C4 Therapeutics (C4T) and Calico today announced a five-year collaboration to discover, develop, and commercialize therapies for treating diseases of aging, including cancer. Under…
Read More...

BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today that it has acquired Agalimmune Ltd., a private UK-based company with an…
Read More...

Intec Pharma Ltd., a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ platform technology, announces the initiation of a…
Read More...

Moleculin Biotech, Inc., a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The…
Read More...

Aprea Therapeutics, a privately held, clinical stage biopharmaceutical company developing novel anticancer therapies targeting the tumor suppressor protein p53, today announced a…
Read More...

Pierre Fabre, the second largest privately held pharmaceutical company in France, and H-Immune SAS, an emerging biotechnology company focused on developing first in class…
Read More...

argenx, a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, today…
Read More...

Pulmatrix a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases announced that it has received a key patent from the…
Read More...

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced…
Read More...